EUVIMEDEUVIMED entdecken
Crossref

Integrating Plasma Metabolomics, Network Pharmacology, and Experimental Validation to Investigate the Action Mechanism of Qiangxin Lishui Prescription in Chronic Heart Failure

Yong Jiang iD, Wenjun Ji, Ying Lu, Qin Wang iD, Linwei Chen iD

Biomedical Chromatography · 2025

DOI: 10.1002/bmc.6065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Yong Jiang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Heart Failure, Network Pharmacology, Metabolomics. Die Arbeit nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Youth Medical Innovation Research Project of China, Nanjing Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The high mortality rate of chronic heart failure (CHF) makes it a primary battlefield in the field of cardiovascular diseases. Qiangxin Lishui Prescription (QLP) is a traditional Chinese medicine (TCM) prescription used clinically for treating CHF, but its underlying mechanism remains unclear. This study integrated plasma metabolomics, network pharmacology, and experimental validation to reveal the pharmacological effects of QLP and its potential mechanism of anti‐CHF. Using ultra‐high‐performance liquid chromatography combined with quadrupole time‐of‐flight mass spectrometry (UPLC‐Q/TOF‐MS/MS), 119 absorbed prototype compounds of QLP were identified from rat plasma. By applying network pharmacology and molecular docking techniques, a QLP absorption components–target–CHF network was constructed. The IL6/JAK/STAT3 signaling pathway is likely critical to QLP's therapeutic effect on CHF. A CHF mouse model was established using aortic ligation surgery to investigate the regulation of the IL6/JAK/STAT3 pathway by QLP in CHF mice. Network pharmacology analysis and in vivo experimental data indicate that QLP alleviates myocardial injury and inflammatory response in CHF mice by modulating the IL6/JAK/STAT3 pathway, significantly improving cardiac function. This presents a promising therapeutic strategy for CHF treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalHeart FailureNetwork PharmacologyMetabolomicsTandem Mass SpectrometryRats, Sprague-DawleyAnimalsRatsMiceMaleChromatography, High Pressure LiquidMice, Inbred C57BLDisease Models, AnimalMolecular Docking SimulationMetabolomeChronic DiseaseSTAT3 Transcription FactorInterleukin-6Janus KinasesSignal Transduction

Stichwörter der Autor:innen

Qiangxin Lishui Prescriptionchronic heart failureexperimental validationnetwork pharmacologyplasma metabolomics

Substanzen

Drugs, Chinese HerbalSTAT3 Transcription FactorInterleukin-6Janus Kinases

Autor:innen und Institutionen

  • Department of Pharmacy, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, China.
  • Department of Pharmacy, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, China.

ORCID-Profile: Yong Jiang, Qin Wang, Linwei Chen

Förderung

  • National Natural Science Foundation of China
  • Youth Medical Innovation Research Project of China
  • Nanjing Medical University
  • Science and Technology Support Project of Taizhou

Zitieren

APA

Jiang, Y., Ji, W., Lu, Y., Wang, Q., & Chen, L. (2025). Integrating Plasma Metabolomics, Network Pharmacology, and Experimental Validation to Investigate the Action Mechanism of Qiangxin Lishui Prescription in Chronic Heart Failure. Biomedical Chromatography. https://doi.org/10.1002/bmc.6065

Vancouver

Jiang Y, Ji W, Lu Y, Wang Q, Chen L. Integrating Plasma Metabolomics, Network Pharmacology, and Experimental Validation to Investigate the Action Mechanism of Qiangxin Lishui Prescription in Chronic Heart Failure. Biomedical Chromatography. 2025. doi:10.1002/bmc.6065

BibTeX
@article{Jiang2025,
  author = {Jiang, Yong and Ji, Wenjun and Lu, Ying and Wang, Qin and Chen, Linwei},
  title = {Integrating Plasma Metabolomics, Network Pharmacology, and Experimental Validation to Investigate the Action Mechanism of Qiangxin Lishui Prescription in Chronic Heart Failure},
  journal = {Biomedical Chromatography},
  year = {2025},
  doi = {10.1002/bmc.6065}
}
Kostenlos starten →